Comparison of PPAR-alpha immunostaining in steatohepatitis and normal liver biopsies

被引：0
|
作者：
DeHaan, RD [1 ]
Sanderson, SO [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
LABORATORY INVESTIGATION | 2005年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1286
引用
收藏
页码：278A / 278A
页数：1
相关论文
共 50 条
  • [1] Comparison of PPAR-alpha immunostaining in steatohepatitis and normal liver biopsies
    DeHaan, RD
    Sanderson, SO
    MODERN PATHOLOGY, 2005, 18 : 278A - 278A
  • [2] PPAR-alpha L162V polymorphism in nonalcoholic steatohepatitis.
    Verdi, H
    Koytak, ES
    Ergul, AA
    Idilman, R
    Uzunalimoglu, O
    Yurdaydin, C
    Bozkaya, H
    HEPATOLOGY, 2004, 40 (04) : 588A - 588A
  • [3] PPAR-alpha in cutaneous inflammation
    Dubrac, Sandrine
    Schmuth, Matthias
    DERMATO-ENDOCRINOLOGY, 2011, 3 (01) : 23 - 26
  • [4] APAP induced liver damage is prevented by activation of PPAR-gamma and PPAR-alpha
    Gomez-Jauregui, Paul
    Gonzalez-Romero, Francisco
    Gomez Santos, Beatriz
    Apodaka-Biguri, Maider
    Buque, Xabier
    Crespo, Maria
    Mora, Alfonso
    Mesquita, Mariana
    Aurrekoetxea, Igor
    Delgado, Igotz
    Nieva-Zuluaga, Ane
    Ruiz De Gauna, Mikel
    Fernandez-Puertas, Idoia
    Sainz-Ramirez, Natalia
    Alfaro-Jimenez, Kendall
    Esther Irizar, Maria
    Iglesias, Ainhoa
    Javier Cubero, Francisco
    Sabio, Guadalupe
    Zubiaga, Ana
    Aspichueta, Patricia
    JOURNAL OF HEPATOLOGY, 2024, 80 : S112 - S113
  • [5] TNF-alpha mediates the ethanol induced PPAR-alpha supression in the liver
    Onder, F. O.
    Sengul, S.
    Calayoglu, R.
    Savas, B.
    Cinar, K.
    Akbiyik, F.
    Yurdaydin, C.
    Uzunalimoglu, O.
    Ataoglu, H.
    Bozkaya, H.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S281 - S281
  • [6] PPAR-alpha activation prevents diabetes mellitus in OLETF rats: Comparison with PPAR-gamma
    Koh, EH
    Park, HS
    Ryu, JW
    Kim, MS
    Park, JY
    Lee, KU
    DIABETES, 2003, 52 : A124 - A124
  • [7] PPAR-alpha agonists suppress lymphangiogenesis
    Hrgovic, I.
    Koeng, V.
    Kleemann, J.
    Doll, M.
    Kaufmann, R.
    Kippenberger, S.
    Meissner, M.
    EXPERIMENTAL DERMATOLOGY, 2017, 26 (03) : E23 - E23
  • [8] Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver
    Cariello, NF
    Romach, EH
    Colton, HM
    Ni, H
    Yoon, L
    Falls, JG
    Casey, W
    Creech, D
    Anderson, SP
    Benavides, GR
    Hoivik, DJ
    Brown, R
    Miller, RT
    TOXICOLOGICAL SCIENCES, 2005, 88 (01) : 250 - 264
  • [9] A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF PPAR-ALPHA AGONIST FENOFIBRATE IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)
    Conjeevaram, Hari S.
    McKenna, Barbara J.
    Kang, Hellan
    Oral, Elif A.
    Omo, Jason
    White, Diane
    Burant, Charles F.
    HEPATOLOGY, 2009, 50 (04) : 774A - 774A
  • [10] Transcriptional Regulation of Cardiomyocyte PPAR-Alpha by Stretch
    Rodriguez, Jessica
    Case, Natasha
    Li, Luge
    Rubin, Janet
    Willis, Monte S.
    FASEB JOURNAL, 2009, 23
12345